(Q84019269)
Statements
Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement (English)
Hartmut Goldschmidt
Tilmann Bochtler
Arnt V Kristen
Ute Hegenbart
Ernst Hund
Axel Benner
Jörg Beimler
Markus Zorn